Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1118 of 6351
-
Cancer drug shows promise in slowing rare tumor growth
Disease control CompletedThis randomized phase III trial compares the effects, good and/or bad, of sorafenib tosylate in treating patients with desmoid tumors or aggressive fibromatosis. Sorafenib tosylate may stop the growth of tumor cells by blocking some of the proteins needed for cell growth. \[Fundi…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for advanced colon cancer: immune drug shrinks tumors in genetic subtype
Disease control CompletedThe purpose of this study is to examine if Nivolumab by itself, or Nivolumab in combination with other anti-cancer drugs, will result in meaningful tumor size reduction, in participants with colon cancer that has come back or has spread, and who have a specific biomarker in their…
Phase 2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Heart shield for young cancer survivors: new study tests dexrazoxane
Disease control Recruiting nowThis clinical trial studies the effects of dexrazoxane hydrochloride on biomarkers associated with cardiomyopathy and heart failure after cancer treatment. Studying samples of blood in the laboratory from patients receiving dexrazoxane hydrochloride may help doctors learn more ab…
Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Stem cells aim to tame heart failure in landmark trial
Disease control CompletedThe primary objective of this study is to determine whether transendocardial delivery of allogeneic human bone marrow-derived mesenchymal precursor cells (MPCs \[rexlemestrocel-L\]) is effective in the treatment of chronic heart failure (HF) due to left ventricular (LV) systolic …
Phase 3 • Sponsor: Mesoblast, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Custom stent grafts offer new hope for High-Risk aneurysm patients
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and efficacy of custom made devices, Zenith t-Branch devices and physician modification of FDA approved off-the-shelf endovascular grafts in the treatment of patients with complex abdominal aneurysms, aortoiliac aneurysms, thora…
Sponsor: Andres Schanzer • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New pill combo shows promise for cystic fibrosis patients
Disease control CompletedThe objective of this study was to evaluate the safety and efficacy of VX-661in combination with ivacaftor in participants with cystic fibrosis (CF) who are homozygous for F508del cystic fibrosis transmembrane conductance regulator (CFTR) mutation
Phase 2 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Less invasive Stent-Graft aims to fix dangerous aortic bulges
Disease control Recruiting nowThe purpose of this study is to gather safety and effectiveness of the Zenith t-Branch and customized physician-specified stent-graft with a combination of fenestrations and/or branches to repair aortic aneurysm.
Sponsor: Gustavo S Oderich • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New drug combo aims to stop liver cancer recurrence in transplant patients
Disease control By invitation onlyThis study is a prospective Phase IV study to determine if the use of Everolimus results in lower liver tumor recurrence and improved patient and graft survival after liver transplant for hepatocellular carcinoma (HCC). The immunosuppressive comparators will be Everolimus and Tac…
Phase 4 • Sponsor: Baylor Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New pill targets rare gene mutation in Hard-to-Treat blood cancers
Disease control Recruiting nowThe purpose of this Phase I, multicenter study is to evaluate the safety, pharmacokinetics, pharmacodynamics and clinical activity of AG-120 in advanced hematologic malignancies that harbor an IDH1 mutation. The first portion of the study is a dose escalation phase where cohorts …
Phase 1 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Personalized maintenance therapy: a smarter way to treat advanced cancer?
Disease control Recruiting nowThe MOST Plus study is a two-period phase II clinical trial, conducted in patients with all types of progressive solid tumors after at least 1 prior systemic treatment regimen for advanced disease (in the absence of a validated second line therapy). The main goal of this study i…
Phase 2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Poles apart? nordic walking may outpace standard rehab for heart failure
Symptom relief CompletedThe main purpose of our project is to see if a 12-week program of Nordic walking is better than standard exercise therapy for increasing exercise capacity (measured by how far people can walk in 6 minutes) and increasing quality of life (measured by having people fill out two que…
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Can a ketamine boost during surgery slash opioid needs?
Symptom relief CompletedThe investigators want to investigate the effect of low dose S+ ketamine compared to placebo on cumulative morphine consumption at 24 hours in 90 women undergoing open abdominal hysterectomy with remifentanil-propofol target controlled infusion (TCI) in KK Women's and Children's …
Phase 2 • Sponsor: KK Women's and Children's Hospital • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Can a drug combo shrink breast tumors better before surgery?
Disease control OngoingThe study is being conducted to determine whether neoadjuvant endocrine therapy with fulvestrant or the combination of anastrozole and fulvestrant, is better than anastrozole when given before surgery to shrink the cancer and stop it from growing. Anastrozole inhibits tumor growt…
Phase 3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New hope for advanced lung cancer: durvalumab shows promise in trial
Disease control CompletedA study to assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer in terms of efficacy, safety and tolerability
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Timing chemotherapy around bladder surgery may cut recurrence
Disease control CompletedThis study seeks to optimize the management of TVNIM (reduction of the risk of reccurence of the disease) by comparing in terms of efficacy and tolerance the immediate preoperative administration of mitomycin C (IPOI) to an early postoperative administration (IPOP). It's a natio…
Sponsor: Poitiers University Hospital • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New chemo combo aims to stop leukemia return after transplant
Disease control OngoingThis phase II trial studies how well clofarabine and melphalan before a donor stem cell transplant works in treating patients with a decrease in or disappearance of signs and symptoms of myelodysplasia or acute leukemia (disease is in remission), or chronic myelomonocytic leukemi…
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Jaw surgery offers new hope for sleep apnea sufferers
Disease control Recruiting nowThis study looks at how jaw surgery called maxillomandibular advancement with counterclockwise rotation affects breathing during sleep in people with moderate to severe obstructive sleep apnea who cannot tolerate standard treatments such as Continous Positive Airway pressure trea…
Sponsor: Jani Talvilahti • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Supercharged donor cells take on viruses after transplant
Disease control Recruiting nowIn this research study, the investigators want to learn more about the use of donor-derived viral specific T-cells (VSTs) to treat viral infections that occur after allogeneic stem cell transplant. A viral specific T cell is a T lymphocyte (a type of white blood cell) that kills …
Phase 1/2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Milder transplant method aims to help young patients with rare blood diseases
Disease control Recruiting nowThe objective of this study is to evaluate the efficacy of using a reduced-intensity condition (RIC) regimen with umbilical cord blood transplant (UCBT), double cord UCBT, matched unrelated donor (MUD) bone marrow transplant (BMT) or peripheral blood stem cell transplant (PBSCT) …
Phase 2 • Sponsor: Paul Szabolcs • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Artificial pancreas implant shows promise for diabetes control
Disease control OngoingThe primary objective of this clinical investigation is to investigate the safety of implantation of the human islet containing device Beta-Air in type 1 diabetic subjects. The secondary objective of this clinical investigation is to investigate if the transplantation of macro-e…
Phase 1/2 • Sponsor: Uppsala University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC